| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |